BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 23011823)

  • 1. The frequency and significance of WT-1 expression in serous endometrial carcinoma.
    Hedley C; Sriraksa R; Showeil R; Van Noorden S; El-Bahrawy M
    Hum Pathol; 2014 Sep; 45(9):1879-84. PubMed ID: 25033726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARID1 and BRG1 Expression in Endometrial Cancer.
    Kontomanolis EN; Symeonidis P; Nikolettos K; Perros P; Rody A; Tsikouras P; Nikolettos N; Giatromanolaki A
    In Vivo; 2024; 38(3):1260-1265. PubMed ID: 38688602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Ret finger protein correlates with outcomes in endometrial cancer.
    Tsukamoto H; Kato T; Enomoto A; Nakamura N; Shimono Y; Jijiwa M; Asai N; Murakumo Y; Shibata K; Kikkawa F; Takahashi M
    Cancer Sci; 2009 Oct; 100(10):1895-901. PubMed ID: 19650860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the localization of chondroitin sulfate in various types of endometrial carcinoma.
    Hosokawa S; Norimatsu Y; Shinagawa A; Kurokawa T; Yoshida Y; Nishikawa T; Suzuki H; Irino S; Kobayashi TK
    PLoS One; 2024; 19(5):e0304420. PubMed ID: 38805498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial serous carcinoma: its molecular characteristics and histology-specific treatment strategies.
    Nakayama K; Nakayama N; Ishikawa M; Miyazaki K
    Cancers (Basel); 2012 Aug; 4(3):799-807. PubMed ID: 24213467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women.
    Audet-Delage Y; Villeneuve L; Grégoire J; Plante M; Guillemette C
    Front Endocrinol (Lausanne); 2018; 9():87. PubMed ID: 29593653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed neuroendocrine and endometrioid carcinoma of the endometrium: a rare aggressive malignancy.
    Bakshi N; Modi RD; Srivastava M; Badwal S
    Int J Gynecol Cancer; 2024 Jan; ():. PubMed ID: 38182264
    [No Abstract]   [Full Text] [Related]  

  • 8. TRIM27 functions as an oncogene by activating epithelial-mesenchymal transition and p-AKT in colorectal cancer.
    Zhang Y; Feng Y; Ji D; Wang Q; Qian W; Wang S; Zhang Z; Ji B; Zhang C; Sun Y; Fu Z
    Int J Oncol; 2018 Aug; 53(2):620-632. PubMed ID: 29767249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trim27 interacts with Slx2, is associated with meiotic processes during spermatogenesis.
    Zhuang XJ; Tang WH; Feng X; Liu CY; Zhu JL; Yan J; Liu DF; Liu P; Qiao J
    Cell Cycle; 2016 Oct; 15(19):2576-2584. PubMed ID: 27612028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of TRIM27 expression inhibits the proliferation of ovarian cancer cells in vitro and in vivo.
    Ma Y; Wei Z; Bast RC; Wang Z; Li Y; Gao M; Liu Y; Wang X; Guo C; Zhang L; Wang X
    Lab Invest; 2016 Jan; 96(1):37-48. PubMed ID: 26568293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
    Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
    Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.
    Lax SF; Kurman RJ
    Verh Dtsch Ges Pathol; 1997; 81():228-32. PubMed ID: 9474874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective expression of ret finger protein in endometrial cancer: can RFP be a marker of serous carcinomas?
    Tezel GG; Ordulu Z; Hımmetoğlu C; Usubütün A
    Turk Patoloji Derg; 2012; 28(3):213-9. PubMed ID: 23011823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
    Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
    Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.